InvestorWire NewsRoom

Article

DGE’s 4th Aligning Drug Safety Functions & REMS Summit: A Groundbreaking Event for Patient Safety
June 1, 2023

DGE’s 4th Aligning Drug Safety Functions & REMS Summit: A Groundbreaking Event for Patient Safety

Pharma, biotech, medical device, healthcare, and regulatory professionals are gathering for the 4th Aligning Drug Safety Functions & REMS Summit, taking place on August 29-30, 2023, at The Inn at Penn in Philadelphia, PA.

Set to take place in the beautiful city of Philadelphia, the conference will delve into the latest insights and address the most critical challenges surrounding drug safety and REMS (Risk Evaluation & Mitigation Strategy).

As the only event that brings together drug safety, pharmacovigilance, and risk management teams—no other conference provides as much detail and comprehensive insights into communication strategies among safety teams, prioritizing patient safety, and preparing for pharmacovigilance and REMS inspections. Attendees will walk away armed to effectively up their game and amplify patient feedback and participation in REMS programs.

Interactive and Inspirational Discussions!

With a well-rounded agenda focused on the latest advances in drug safety and REMS space, the program is designed to provide attendees with all the tools they need to develop and implement a robust global risk management plan.

Featuring interactive discussions, such as exploring the critical intersection of REMS and pharmacovigilance in shared REMS systems, discovering the power of AI to optimize REMS implementation, strategies to improve signal management and detection, fortifying compliance and quality in post-approval studies. Delve into the cutting-edge realm of patient-centricity for benefit-risk assessment and their implications for the future of healthcare.

Throughout the two-day summit, attendees will be able to connect with an outstanding lineup of expert speakers and industry leaders and learn network, and interchange ideas and innovative approaches surrounding drug safety and REMS strategies to better support patient safety.

Sign up and forge a safer and more patient-centric future at the most trusted drug safety event. Interested participants can register for this summit and secure their tickets at early-bird prices.

To learn more, please visit https://ibn.fm/otdWA.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).